baber/WOPTO huggingface dataset:
Patent JP-2001513780-A (JP)
IPC: A61K8/35
Filed: 1998-02-27
Abstract: The invention relates to an active ingredient combination containing erythrulose and a further reducing sugar with self-tanning properties, for example, dihydroxyacetone, which combination is used for artificially tanning the skin. Compared with compounds containing, for example, only dihydroxyacetone, said active ingredient combination and cosmetic compounds based thereon result in an even and longer-lasting colouring of the skin and prevent skin dehydration and uneven flaking.
Patent JP-2001526557-A (JP)
Title: 生物学的測定システム
IPC: A61B5/00
Filed: 1998-03-09
Abstract: (57)【要約】
血中のブドウ糖などの生理学的パラメーターは、フォトアコースティック相互作用を生じさせるために、光学ガイド１０からのレーザー光のパルスを、柔組織から成る指先１２のような身体の一部に誘導することによって、測定される。その結果生じるアコースティック信号はパラメーターを提供するためにトランデューサ１６によって検知、分析される。
Patent JP-2000509327-A (JP)
Title: フィルタ材料及びフィルタ材料の製法並びにこのフィルタ材料から製作された吸着フィルタ
IPC: B01J20/28
Filed: 1997-05-02
Abstract: (57)【要約】
本発明の対象は面状の担持体を有し、該担持体の片側又は両側に、加熱下で接着性になる付着層が設けられ、該付着層に吸着材料が固定されている、吸着性質を有するフィルタ材料である。このフィルタ材料の少なくとも２つの層から吸着フィルタを製造することができる。さらに本発明は前述のフィルタ材料の製造方法をも対象としている。
Patent JP-2001514577-A (JP)
Title: 光ファイバケーブル掃除器
IPC: B08B11/00
Filed: 1998-02-23
Abstract: (57)【要約】
光ファイバ清掃装置は、表面を有する本体を備える。清掃物質は、該本体の表面に付着する。該本体は、前記清掃物質を前記光ファイバに選択的に接触させるように選択的に配置可能である。
Patent JP-2000513649-A (JP)
Title: 食品加工装置におけるオゾン処理を用いての微生物抑制方法
IPC: C02F1/00
Filed: 1996-12-04
Abstract: (57)【要約】
本発明は、オゾンを含む水流及び水系装置の処理に関する。水系装置は、様々な生産物を生産位置から加工位置まで輸送するための閉ループ装置を含む。水流は、攻撃汚染負荷及び微生物負荷を含み得る。処理ゾーンとは、水流がその中を通過するものと定義される。処理ゾーンは、十分な濃度のオゾンと接触し、微生物個体数を実質的に減少させ、装置内部でスライムを発生させるおそれのある微生物数を実質的に減少させる。微生物個体数を安全なレベルにまで減少させ、オゾン濃度を作業者や生産物が接触しても実質的に安全なレベルにまで減少させる程度の量のオゾンが、処理ゾーンの水流に添加される。通常、そのような濃度とは、水系装置１００万重量部に対しオゾン１重量部未満、好ましくは水系装置１００万重量部に対しオゾン０．５部重量部未満である。水系装置で処理ゾーンを使用することによって、作業員や反応し易い物質、又は生産物がしばしば出入りする領域へのオゾンの放出が回避される。
Patent JP-2000516903-A (JP)
Title: ガラス組成物及び化学強化されるガラスで製造された基材
IPC: C03C3/091
Filed: 1998-04-09
Abstract: (57)【要約】
本発明は、重量割合でＳｉＯ 2 を５５〜７１％、Ａｌ 2 Ｏ 3 を＞２％、ＭｇＯを４〜１１％但しＡｌ 2 Ｏ 3 ＜５％ならば＞８％、Ｎａ 2 Ｏを９〜１６．５％、Ｋ 2 Ｏを４〜１０％含むガラス構造物にするガラス組成物に関する。
Patent JP-2000504350-A (JP)
Title: キトサン誘導性免疫強化
IPC: A61K31/715
Filed: 1997-03-25
Abstract: (57)【要約】
免疫応答を強化するための方法および組成物が開示され、これは免疫強化アジュバントとしてキトサンを取り込む。本発明の組成物の投与は、種々の経路によりもたらされる。
Patent JP-2002510250-A (JP)
Title: 指支持構造
IPC: B25G1/10
Filed: 1998-04-28
Abstract: (57)【要約】
指支持構造F(finger supporting structure F)は把持部位(grip portion)とここに形成された指支持部(finger supporter)Tで構成されている。この把持部位(grip portion)は長い棒状として手のつかむ適当な長さと太さを有している。この把持部位は一定道具の把持メンバー(grasping  member)の一定部分又は全部分で構成されるか或は一定道具の把持メンバーを受容する内部孔を有する把持部材Ｇの一定部分又は全部分で構成される。この指支持部Ｔは把持部位の表面に一側に延長された突出部であって単一の一つの胴体に堅固に(rigidly)形成される。指と手の筋肉の合成力が最大に形成され発揮されるようにこの指支持部Ｔは把持部位の軸Ｘに対して傾くように形成される。この指支持構造Ｆが様々な道具の把持メンバーに実施された結果、指支持部Ｔを有する把持部Ｈを道具に提供することになる。
Patent JP-2001527463-A (JP)
Title: カルボン酸塩の調製方法及び該方法に有用な触媒
IPC: C07C51/41
Filed: 1998-05-05
Abstract: (57)【要約】
カルボン酸塩の調製に有用な担持された触媒であり、この触媒は、耐アルカリ性担体、オスミウム、イリジウム及びロジウムからなる群から選択される多数の金属粒子、及び、銅、コバルト、ニッケル、カドミウム又はそれらの混合物からなる群から選択される、触媒作用で活性な金属からなるコーティングからなる。
Patent JP-2001525827-A (JP)
Title: 多嚢胞性卵巣症候群および妊娠糖尿病の治療における５−（４−（２−（ｎ−メチル−ｎ−（２−ピリジル）アミノ）−エトキシ）ベンジル）２，４−チアゾリジンジオンの使用
IPC: A61P3/10
Filed: 1998-05-14
Abstract: (57)【要約】
インシュリン非依存性糖尿病(NIDDM)の発症およびそれから生じる合併症の危険性のあるヒトを治療する、チアゾリジノン誘導体および関連する抗高血糖剤の新規な使用方法を開示する。一つの態様において、本発明の化合物は、多嚢胞性卵巣症候群を治療し、インシュリン非依存性糖尿病の発症を予防または遅延させるために使用される。別の態様において、本発明の化合物は、妊娠糖尿病を治療し、インシュリン非依存性糖尿病の発症を予防または遅延させるために使用される。
Patent JP-2001527650-A (JP)
Title: タイヤの圧力を検出する方法と装置
IPC: G01M17/02
Filed: 1998-05-15
Abstract: (57)【要約】
例えば、タイヤ交換時タイヤを膨らませている間車両から外した状態でタイヤ圧を検出する方法と装置は、振動による衝撃を入力し、圧電ケーブル変換器によって対応する波形を発生させることに基づいている。圧力に関する振動数あるいは時間ベースのシフトにより波形出力を分析することによって顕著なピークを識別することに基づいて数値圧力検出の基準を提供する。タイヤを膨らませる間ソレノイド作動のハンマ装置によって一定レベルの衝撃を繰り返すことによって顕著なピークと、従って膨らませ圧力とをモニタすることが出来る。
Patent MX-160913-A (MX)
Inventor: BARKER MARTYN CHARLES
IPC: C03C1/04
Filed: 1983-05-13
Abstract: loccular compositions comprising ultrafine inorganic particles having maximum particle dimensions of from 0.5 to 3000 (preferably 2 to 1500) nm combined with a size-stabiliser which is a lyophobic substance with lyophilic activity on its surface and also comprising a polyelectrolyte flocculating agent attached to the combination. The size-stabiliser protects the ultrafine particles against agglomeration during formation of the flocculates and the mixing of flocculates into various materials such as plastics, inks, paint or refractory materials. Also a method for making the flocculates from colloidal dispersions of particles, size-stabilisers and flocculating agents. The flocculates are particularly useful with particles of metals of the coinage and transition groups for making transparent colouring agents. Also materials containing the ultrafine particles.
Patent MX-158577-A (MX)
Inventor: MARECHAL ROGER
IPC: B23Q1/26
Filed: 1983-12-15
Abstract: The device for cutting blocks of granite, marble, stone and other like materials by means of diamond blades displaced in a reciprocating movement by a blade carrying frame, said blade carrying frame being itself connected to a reciprocating motor unit, characterized in that at least the blade carrying frame is connected to a sliding frame by means of vibration damping means.
Patent NZ-196398-A (NZ)
Title: Permanent dental restorative compositions
Inventor: FELLMAN R P
IPC: A61K6/884
Filed: 1981-03-03
Abstract: Permanent dental restoration compositions comprise (a) from 25 to 80 parts by weight of liquid monomer system comprising methyl methacrylate and from 15 to 50%, by weight of the system, of at least one polyethylenically unsaturated monomer; (b) from 20 to 75 parts by weight of (1) organic polymeric particulate substance and (2) inorganic particulate substance, (1) and (2) being insoluble in the monomer system, and (c) redox initiator. The compositions may be used to form crowns, bridges or fillings or for dental repair in general. Crowns, for example, may be prepared by mixing a composition comprising (a) and reducing agent with a composition comprising (b) and oxidising agent, filling a mould with the mixture, applying the mould to a tooth stump to set, removing the set crown for polishing and finishing, filling it with cement and applying it to the stump.
Patent NZ-210040-A (NZ)
Title: Oligomers containing both triazine and oxazoline groups and epoxy resins prepared therefrom
Inventor: HEFNER ROBERT E JR
IPC: C08G59/04
Filed: 1984-10-30
Abstract: This invention pertains to a process for preparing hydroxyaromatic oligomers containing triazine groups and oxazoline groups. The process is characterized by (I) reacting (A) a material having an average of more than one aromatic hydroxyl group per molecule with (B) a cyanogen halide such as cyanogen bromide in the presence of a base and recovering a mixture of cyanate-containing products and unreacted (A) materials, (II) co-oligomerizing the product resulting from (I) with an epoxy resin in the presence of a suitable co-oligomerization catalyst. This invention also pertains to a process for preparing epoxy resins containing both triazine groups and oxazoline groups by epoxidizing a hydroxyaromatic material in a conventional manner by reaction with an epihalohydrin with subsequent dehydrohalogenation with a basic-acting material and finally recovering the resultant glycidyl ether product, characterized in that the hydroxyaromatic material is the resultant co-oligomerization product from step (II) of the earlier process.
Patent NZ-226414-A (NZ)
Title: Cd4 peptide adhesion variants and their preparation and use
Inventor: CAPON DANIEL J
IPC: C07K19/00
Filed: 1988-09-30
Abstract: Novel derivatives of cell surface proteins which are homologous to the immunoglobulin superfamily (adhesons) are provided. Amino acid sequence variations are introduced into adheson, the most noteworthy of which are those in which the transmembrane and, preferably, cytoplasmic domains are rendered functionally inactive, and in which adheson extracellular domains replace an immunoglobulin variable region. These variants are useful in therapy or diagnostics, in particular, CD4 variants are therapeutically useful in the treatment of HIV infections.
Patent NZ-238752-A (NZ)
Title: Diaminotrifluoromethyl pyridine derivatives, intermediates and medicaments
Inventor: TAKAHIRO HAGA
IPC: C07D405/12
Filed: 1991-06-27
Abstract: A diaminotrifluoromethylpyridine derivative of the formula (I) or its salt: <CHEM> wherein X is -CW<1>R<1>, -COCOR<2>, -CW<1>NHCOR<2>, -C(=W<1>)W<2>R<3> or -CW<1>N(R<4>)R<5>, and Y is alkyl, -CW<3>R<6>, -COCOR<7>, -NHCOR<7>, -C(=W<3>)W<4>R<8>, -(NH)mSO2R<9>, -(NH)mSO2OR<1><0> or -(NH)mSO2N(R<1><1>)R<1><2>, wherein each of R<1>, R<6> and R<9>, which are independent from one another, is a chain hydrocarbon group which may be substituted, a monocyclic hydrocarbon group which may be substituted, a polycyclic hydrocarbon group which may be substituted, a monocyclic heterocycle group which may be substituted or a polycyclic heterocycle group which may be substituted, each of R<2> and R<7>, which are independent from each other, is alkyl which may be substituted, alkoxy which may be substituted, phenyl which may be substituted or phenoxy which may be substituted, each of R<3>, R<8> and R<1><0>, which are independent from one another, is alkyl which may be substituted, alkenyl which may be substituted, alkynyl which may be substituted, cycloalkyl which may be substituted, phenyl which may be substituted or benzyl which may be substituted, each of R<4>, R<5>, R<1><1> and R<1><2>, which are independent from one another, is alkyl which may be substituted, each of W<1>, W<2>, W<3> and W<4>, which are independent from one another, is an oxygen atom or a sulfur atom, and m is 0 or 1, provided that a combination wherein one of X and Y is -COCF2X<1> wherein X<1> is a hydrogen atom, a halogen atom, alkyl or haloalkyl, and the other is -COCF2X<2> wherein X<2> is a hydrogen atom, a halogen atom, alkyl, haloalkyl or alkylcarbonyl, or -COOX<3> wherein X<3> is alkyl which may be substituted or phenyl which may be substituted, is excluded.
Patent NZ-267487-A (NZ)
Title: 5-arylindole derivatives and pharmaceutical compositions thereof
Inventor: MACOR JOHN E
IPC: A61P25/20
Filed: 1996-02-08
Abstract: wherein A, B, D, E, and F are each independently nitrogen or carbon; R1 is hydrogen, C1 to C6 alkyl, -(CH2)nR7, or C1 to C3 alkyl-aryl; R2, R3, R4, R5 and R6 are each independently hydrogen, C1 to C6 alkyl, aryl, C1 to C3 alkyl-aryl, halogen, cyano, nitro, -(CH2)mNR8R9, -(CH2)mOR9, -SR8, -SO2NR8R9, -(CH2)mNR8SO2R9, -(CH2)mNR8CO2R9, -(CH2)mNR8COR9, -(CH2)mCONR7R9, or -(CH2)mCO2R9; R2 and R3, R3 and R4, R4 and R5, and R5 and R6 may be taken together to form a five- to seven-membered alkyl ring, a six-membered ary ring, a five- to seven-membered heteroalkyl ring, having 1 heteroatom of N, O, or S, or a five- to six-membered heteroaryl ring having 1 or 2 heteroatoms of N, O, or S; R7is -OR10, -SR10, -SO2NR10R11, -NR10SO2R11, -NR10CO2R11, -NR10COR11, -CONR10R11, or -CO2R10; R8, R9, R10 and R11 are each independently hydrogen, C1 to C6alkyl, or C1 to C3 alkyl-aryl; m is 0, 1, or 2; n is 2, 3, or 4; and the above aryl groups and the aryl moieties of the above alkyl-aryl groups are each independently phenyl or substituted phenyl, wherein said substituted phenyl may be substituted with one to three of C1 to C4 alkyl, halogen, hydroxy, cyano, carboxamido, nitro, or C1 to C4 alkoxy, and the pharmaceutically acceptable salts thereof. These compounds are useful in treating migraine and other disorders and are new. These compounds are useful psychotherapeutics and are potent serotonin (5-HT1) agonists and may be used in the treatment of depression, anxiety, eating disorders, obesity, drug abuse, cluster headache, migraine, pain, and chronic paroxysmal hemicrania and headache associated with vascular disorders, and other disorders arising from deficient serotonergic neurotransmission. The compounds can also be used as centrally acting antihypertensives and vasodilators.
Patent NZ-282170-A (NZ)
Title: Lens microcartridge comprising a lens receiving portion having the configuration of an oval shaped barrel
Inventor: FEINGOLD VLADIMIR
IPC: A61B17/00
Filed: 1995-02-15
Abstract: A hingeless type intraocular lens microcartridge for use with a surgical insertion instrument. The hingeless microcartridge has a fixed configuration with a transition portion extending between a lens receiving portion and a nozzle portion.
Patent NZ-295877-A (NZ)
Title: A vaccine comprising the helicobacter bacterium and its use
Inventor: PACE JOHN L
IPC: C12Q1/04
Filed: 1995-10-04
Abstract: Methods using in vitro processes are disclosed for inducing or enhancing expression of enteric bacterial antigens or virulence factors. The methods, therefore, produce antigenically enhanced enteric bacteria. Also methods for using the antigenically enhanced bacteria are also disclosed, as well as vaccines containing the enteric bacteria. Specifically a whole enteric bacterium or components thereof are provided by Helicobacter species. Also there are other enteric bacteria which are useful for the disclosed invention; such as Campylobacter jejuni.
Patent NZ-316148-A (NZ)
Title: Reconstituting animal embryos by transferring nuclei into unactivated oocytes
Inventor: CAMPBELL KEITH HENRY STOCKMAN
IPC: A61K35/54
Filed: 1996-08-30
Abstract: method of reconstituting an animal embryo involves transferring a diploid nucleus into an oocyte which is arrested in the metaphase of the second meiotic division.  The oocyte is not activated at the time of transfer, so that the donor nucleus is kept exposed to the recipient cytoplasm for a period of time.  The diploid nucleus can be donated by a cell in either the G0 or G1 phase of the cell cycle at the time of transfer. Subsequently, the reconstituted embryo is activated. Correct ploidy is maintained during activation, for example, by incubating the reconstituted embryo in the presence of a microtubule inhibitor such as nocodazole.  The reconstituted embryo may then give rise to one or more live animal births.  Divisional filed as 335407
Patent NZ-329627-A (NZ)
Title: 8-Heterocyclically substituted 1,3,8-triaza-spiro[4.5]decan-4-ones
Inventor: ADAM GEO
IPC: C07D471/00
Filed: 1998-01-23
Abstract: The present invention relates to 8-substituted-1,3,8-triaza-spiro[4.5]decan-4-on compounds of the formula (I)that are agonists and/or antagonists of the OFQ receptor.  The variables are as described in the specification.  Consequently they will be useful in the treatment of psychiatric, neurological and physiological disorders.
Patent NZ-332648-A (NZ)
Title: Vasoactive amine binding proteins (VABP) and vasoactive amine binding molecules (VABM)
Inventor: PAESEN GUIDO CHRISTIAN
IPC: A61K38/00
Filed: 1997-05-19
Abstract: A vasoactive amine binding protein (VABP) that specifically bind to vasoactive amines with a dissociation constant of less than 10-7 M and which belong to the same protein family as MS-HBP1, FS-HBP1, FS-HBP2 and D.RET6 and which, is derived from blood-feeding ectoparasites, spiders, scorpions, snakes or venomous animals. The VABP is derived from ticks Rhipicephalus appendiculatus or Dermacenter reticularis. The use is for the regulation of the action of vasoactive amines. Vasoactive amines such as histamine and serotonin are mediators of inflammation and regulators of certain physiological processes in animals, including humans.
Patent NZ-334440-A (NZ)
Title: Joint in the body portion of a multi-cell pressure vessel which comprises arcuate outer wall segments
Inventor: WARNER MARK J
IPC: B65D88/00
Filed: 1997-09-03
Abstract: A joint 20 in the body portion 12 of a multi-cell pressure vessel 10 is disclosed. The body portion 12 has a substantially uniform cross section and comprises a plurality of arcuate outer wall segments 16 connected with at least one internal web segment 18. The joint 20 attaches adjacent ends of two arcuate outer wall segments 16 and the end of one internal web segment 18. The joint has a cross section comprising a tab 22 configured at the end of each segment 16 with the tabs 22 of adjacent ends configured for contiguous engagement to form a boss 28 having a proximate neck portion 30 and a distal body portion 32.  The neck portion 30 of the boss has a width smaller than the width of the body portion of the boss.  A retaining member 40 at the end of the internal web segment 18 is configured to capture the boss formed at the adjacent ends of the two arcuate outer wall segments 16. A sealing weld 25 may be utilised to seal adjacent tabs at exposed seam 24. A joint for use in connecting at least a first and a second segment of a structure having a substantially uniform cross section and for bearing a tensile load applied to the segments along a load axis is also disclosed with the joint having a boss having a first and a second pair of outwardly projecting lips each having a load bearing surface.
Patent NZ-335405-A (NZ)
Title: Inflatable signage means and related inflatable signage supporting means
Inventor: GERRITS MARC JURGEN
IPC: E01F9/012
Filed: 1999-07-23
Abstract: Illuminable signage comprising; I) a support comprising an inflatable tube with two parallel upright sections spaced apart with a lateral section between them, the distal ends of the upright sections are adapted to be secured onto a supporting surface, the tube having at least one opening for the inlet of air and one for the outlet of air; and II) two planar signage substrates positioned between the two upright sections so that backlighting can be provided between the two signs; and III) at least one lighting means to provide backlighting; and wherein the lighting means in use can provide backlighting via any suitable sign thereon.
Patent NZ-500977-A (NZ)
Title: Edible compositions including particulated gel formed under the application of shear
Inventor: SOMERVILLE RODNEY JOHN
IPC: A23L29/238
Filed: 1998-04-21
Abstract: Provided is an edible composition which includes a first particulated gel and at least one other particulated gel that gel under the application of shear force.  The first particulated gel is substantially unmixed with any other part or parts. Also provided is an edible composition that includes a particulated gel suspended in a continuous phase of a hydrocolloid gel. Processes for the preparation of such edible compositions are also included.
Patent NZ-503346-A (NZ)
Title: Trap with folded plate spring to form rectangular C shape, and setting and trip device between arms
Inventor: WARBURTON BRUCE
IPC: A01M23/28
Filed: 2000-03-10
Abstract: In a rudimentary embodiment the trap consists of a C-shaped spring with upper and lower surfaces 11,12 and back wall 13, with surfaces 11,12 biased together. The trap is set by lever arms 19,20 and arm 21, and is triggered by trigger 17 attached to arm 21 via connector 18. More detailed embodiments are disclosed.
Patent NZ-508978-A (NZ)
Title: Naaladase inhibitors useful as pharmaceutical compounds and compositions
Inventor: JACKSON PAUL F
IPC: C07C323/12
Filed: 1999-07-02
Abstract: A compound or a pharmaceutically acceptable equivalent has the formula (I) wherein: X is a moiety of formula II, III or IV m and n are independently 0, 1, 2, 3 or 4; Z is SR13, SO3R13, SO2R13, SOR13, SO(NR13)R14 or S(NR13R14)2R15; B is N or CR16; A is O, S, CR17R18 or (CR17R18)mS; R9 and R13 are hydrogen; R8, R10, R11, R12, R14, R15, R16, R17, R18 and R19 are independently hydrogen, alkyl, alkenyl, cycloalkyl, cycloalkenyl, Ar1, hydroxy, carboxy, carbonyl, amino, amido, cyano, isocyano, nitro, sulphonyl, sulphoxy, thio, thiocarbonyl, thiocyano, formanilido, thioformamido, sulphydryl, halo, haloalkyl, trifluoromethyl or oxy, wherein the alkyl, alkenyl, cycloalkyl and cycloalkenyl are independently optionally substituted with one or more substituents; and Ar1 is an optionally substituted carbocyclic or heterocyclic moiety limited by the proviso as listed in the complete specification. The compounds are useful inhibit NAALADase enzyme inhibitors , thereby effecting neuronal activities, inhibiting angiogenesis, and treating glutamate abnormalities, compulsive disorders, prostate diseases, pain and diabetic neuropathy.
Patent NZ-510211-A (NZ)
Title: Heterocyclic-aminomethylene substituted oxazolidinones useful as antibacterials
Inventor: GRAVESTOCK MICHAEL BARRY
IPC: C07D413/14
Filed: 1999-10-05
Abstract: Compounds of formula (I), or a pharmaceutically-acceptable salt, or an in-vivo-hydrolysable ester thereof are disclosed, wherein, HET is an optionally substituted C-linked 5-membered heteroaryl ring containing 2 to 4 heteroatoms independently selected from N, O and S; Q is selected from, Q1 and Q2; R2 and R3 are independently hydrogen or fluoro; T is selected from a range of groups, for example, an N-linked (fully unsaturated) 5-membered heteroaryl ring system or a group of formula (TC5); wherein Rc is, R13CO-, R13SO2- or R13CS-; wherein R13 is, optionally substituted (C1-C10)alkyl or R14C(O)O(C1-C6)alkyl wherein R14 is optionally substituted ((C1-C10)alkyl; are useful as antibacterial agents; and processes for their manufacture and pharmaceutical compositions containing them are also disclosed.
Patent NZ-513855-A (NZ)
Title: Method for packaging and packaging apparatus
Inventor: STEVENS DAVID J
IPC: B65B9/067
Filed: 2000-09-07
Abstract: A method of packaging comprising the steps of: (i) continuously feeding a packaging material (J) as tubing from a supply (K); (ii) slitting and unfolding said tubing to form a web of said packaging material (J); (iii) forming said flat web of packaging material (J) around a fed product (D) and longitudinally sealing (G) the packaging material (J) formed around the product (D); and (iv) cutting and sealing (A) the packaging material (J) at one or both ends of the product (D).
Patent NZ-514150-A (NZ)
Title: Mounting bracket
Inventor: NICHOLLS KEITH GORDON
IPC: F16B5/00
Filed: 2001-09-12
Abstract: The batten mounting bracket includes a main body (12) having two mounting arms (14, 15) which are inclined and extend away from each other from a junction region (16).  The arms are of different lengths (X, Y), and each mounting arm includes a support surface mounting face (18 and 19) and a batten mounting section along the length of the free edge of each arm by which a batten can be secured to the bracket.  When the mounting face of one mounting arm is secured to a support structure the other mounting arm projects from the support structure in an operative position whereby the batten mounting section can receive a batten.
Patent NZ-516347-A (NZ)
Title: Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
Inventor: BRENDEL JOACHIM
IPC: C07D217/02
Filed: 2000-06-10
Abstract: A compound of formula (1); the preparation thereof; the use to treat K + -channel mediated diseases.
Patent NZ-526534-A (NZ)
Title: An Absorbent Article and a Method for Manufacturing Same
Inventor: SUN ROBERT L
IPC: A61F5/44
Filed: 2001-12-18
Abstract: An absorbent article and a method for manufacturing an absorbent article are disclosed. The absorbent article is made from an inner core absorbent material, which is surrounded by an apertured film. The absorbent material is selected from rayon, cotton, wood pulp, polyester, polyamide, polyolefin, copolymers thereof, and combinations thereof. The absorbent article has a bottom layer, which is made of an apertured film oriented such that protuberances face the inside of the absorbent article. The absorbent article also has a top layer, which is made of an apertured film oriented such that the protuberances face the outside of the absorbent article. The absorbent article may be useful in various applications including sanitary protection and bandages.